These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 1964567)
1. Differentiation of F9 embryonal carcinoma cells by synthetic retinoids: amplitude of plasminogen activator production does not depend on retinoid potency or affinity for F9 nuclear retinoic acid receptors. Bailly J; Delescluse C; Bernardon JM; Charpentier B; Martin B; Pilgrim WR; Shroot B; Darmon M Skin Pharmacol; 1990; 3(4):256-67. PubMed ID: 1964567 [TBL] [Abstract][Full Text] [Related]
2. Biological activity of retinoids correlates with affinity for nuclear receptors but not for cytosolic binding protein. Darmon M; Rocher M; Cavey MT; Martin B; Rabilloud T; Delescluse C; Shroot B Skin Pharmacol; 1988; 1(3):161-75. PubMed ID: 2856163 [TBL] [Abstract][Full Text] [Related]
3. Selective synthetic ligands for human nuclear retinoic acid receptors. Martin B; Bernardon JM; Cavey MT; Bernard B; Carlavan I; Charpentier B; Pilgrim WR; Shroot B; Reichert U Skin Pharmacol; 1992; 5(1):57-65. PubMed ID: 1315557 [TBL] [Abstract][Full Text] [Related]
4. New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. Jetten AM; Anderson K; Deas MA; Kagechika H; Lotan R; Rearick JI; Shudo K Cancer Res; 1987 Jul; 47(13):3523-7. PubMed ID: 2884032 [TBL] [Abstract][Full Text] [Related]
5. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. Clifford J; Chiba H; Sobieszczuk D; Metzger D; Chambon P EMBO J; 1996 Aug; 15(16):4142-55. PubMed ID: 8861943 [TBL] [Abstract][Full Text] [Related]
6. Specific, covalent binding of an azidoretinoid to cellular retinoic acid-binding protein. Martin CA; Dawson MI; McCormick AM; Napoli JL Biochem Biophys Res Commun; 1986 Feb; 135(1):124-30. PubMed ID: 3006677 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. Charpentier B; Bernardon JM; Eustache J; Millois C; Martin B; Michel S; Shroot B J Med Chem; 1995 Dec; 38(26):4993-5006. PubMed ID: 8544175 [TBL] [Abstract][Full Text] [Related]
8. Assessment of retinoid-induced differentiation of F9 embryonal carcinoma cells with an enzyme-linked immunoadsorbent assay for laminin: statistical comparison of dose-response curves. Williams JB; Shields CO; Brettel LM; Napoli JL Anal Biochem; 1987 Feb; 160(2):267-74. PubMed ID: 3034091 [TBL] [Abstract][Full Text] [Related]
9. Retinoid induction of CRABP II mRNA in human dermal fibroblasts: use as a retinoid bioassay. Elder JT; Kaplan A; Cromie MA; Kang S; Voorhees JJ J Invest Dermatol; 1996 Mar; 106(3):517-21. PubMed ID: 8648186 [TBL] [Abstract][Full Text] [Related]
10. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258 [TBL] [Abstract][Full Text] [Related]
11. Embryonal carcinoma cell lines stably transfected with mRARbeta2-lacZ: sensitive system for measuring levels of active retinoids. Sonneveld E; van den Brink CE; van der Leede BJ; Maden M; van der Saag PT Exp Cell Res; 1999 Aug; 250(2):284-97. PubMed ID: 10413584 [TBL] [Abstract][Full Text] [Related]
12. The respecification of limb pattern by new synthetic retinoids and their interaction with cellular retinoic acid-binding protein. Maden M; Summerbell D; Maignan J; Darmon M; Shroot B Differentiation; 1991 May; 47(1):49-55. PubMed ID: 1655545 [TBL] [Abstract][Full Text] [Related]
13. Increased levels of several retinoid binding proteins resulting from retinoic acid-induced differentiation of F9 cells. Eriksson U; Hansson E; Nilsson M; Jönsson KH; Sundelin J; Peterson PA Cancer Res; 1986 Feb; 46(2):717-22. PubMed ID: 3000582 [TBL] [Abstract][Full Text] [Related]
14. Retinoid binding protein activities in murine embryonal carcinoma cells and their differentiated derivatives. Matthaei KI; McCue PA; Sherman MI Cancer Res; 1983 Jun; 43(6):2862-7. PubMed ID: 6303570 [TBL] [Abstract][Full Text] [Related]
15. Cellular retinoic acid-binding protein and its relationship to the biological activity of four synthetic retinoids in hamster tracheal organ culture. Mehta RG; Schiff LJ; Moore SJ; Buckley AM; Dawson MI In Vitro Cell Dev Biol; 1986 Mar; 22(3 Pt 1):164-8. PubMed ID: 2419303 [TBL] [Abstract][Full Text] [Related]
16. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by All-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist. Gendimenico GJ; Stim TB; Corbo M; Janssen B; Mezick JA J Invest Dermatol; 1994 May; 102(5):676-80. PubMed ID: 8176247 [TBL] [Abstract][Full Text] [Related]
17. The relationship among retinoid structure, affinity for retinoic acid-binding protein, and ability to respecify pattern in the regenerating axolotl limb. Keeble S; Maden M Dev Biol; 1989 Mar; 132(1):26-34. PubMed ID: 2537244 [TBL] [Abstract][Full Text] [Related]
18. The effect of dibutyryl cyclic AMP and butyrate on F9 teratocarcinoma cellular retinoic acid-binding protein activity. Grippo JF; Gudas LJ J Biol Chem; 1987 Apr; 262(10):4492-500. PubMed ID: 3031026 [TBL] [Abstract][Full Text] [Related]
19. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines. McCue PA; Thomas RS; Schroeder D; Gubler ML; Sherman MI Cancer Res; 1988 Jul; 48(13):3772-9. PubMed ID: 3378217 [TBL] [Abstract][Full Text] [Related]